Nicola Mazzini
Overview
Explore the profile of Nicola Mazzini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rich S, Nasta P, Quiros-Roldan E, Fusco P, Tondinelli A, Costa C, et al.
Eur J Med Res
. 2023 Aug;
28(1):292.
PMID: 37596688
Background: Integrase strand transferase inhibitors (INSTI), including raltegravir (RAL), elvitegravir (ELV), and dolutegravir (DTG), have demonstrated better efficacy and tolerability than other combination antiretroviral therapy (cART) classes in clinical trials;...
2.
Fusco P, Nasta P, Quiros-Roldan E, Tondinelli A, Costa C, Fornabaio C, et al.
Viruses
. 2023 Apr;
15(4).
PMID: 37112904
: Dolutegravir (DTG) is recommended by international guidelines as a main component of an optimal initial regimen of cART (combination antiretroviral treatment) in people living with HIV (PLWH) and in...
3.
Postorino M, Prosperi M, Foca E, Quiros-Roldan E, Di Filippo E, Maggiolo F, et al.
BMC Infect Dis
. 2017 Mar;
17(1):212.
PMID: 28298195
Background: Atazanavir (ATV) not boosted by ritonavir (uATV) has been frequently used in the past for switching combination antiretroviral therapy (cART). However, the clinical outcomes and predictors of such strategy...
4.
Postorino M, Quiros-Roldan E, Maggiolo F, Di Giambenedetto S, Ladisa N, Lapadula G, et al.
Open AIDS J
. 2016 Aug;
10:136-43.
PMID: 27563366
Background And Objectives: Renal toxicity due to tenofovir (TDF) has been largely described in patients with HIV infection. However, other antiretroviral drugs (such as atazanavir [ATV], especially when boosted by...
5.
Torti C, Raffetti E, Donato F, Castelli F, Maggiolo F, Angarano G, et al.
Int J Epidemiol
. 2015 Oct;
46(2):e12.
PMID: 26445966
No abstract available.